Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,393 | -2,662 | -1,733 | -802 | -3,701 |
| Depreciation Amortization | 6 | 3 | N/A | N/A | 90 |
| Accounts receivable | N/A | N/A | N/A | N/A | -4 |
| Other Working Capital | 552 | -258 | 162 | -36 | 299 |
| Other Operating Activity | 1 | 1 | 1 | 0 | 90 |
| Operating Cash Flow | $-3,834 | $-2,917 | $-1,570 | $-838 | $-3,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 974 | 1,149 | 1,149 | 150 | -4,147 |
| Purchase Of Investment | N/A | -138 | -98 | -53 | N/A |
| Investing Cash Flow | $974 | $1,011 | $1,052 | $98 | $-4,147 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,415 | 3,415 | 1,673 | N/A | N/A |
| Common Stock Repurchased | -173 | -173 | -173 | -116 | -471 |
| Financing Cash Flow | $3,242 | $3,242 | $1,500 | $-116 | $-471 |
| Beginning Cash Position | 3,524 | 3,524 | 3,524 | 3,524 | 11,367 |
| End Cash Position | 3,906 | 4,861 | 4,506 | 2,668 | 3,524 |
| Net Cash Flow | $382 | $1,337 | $982 | $-856 | $-7,843 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,834 | -2,917 | -1,570 | -838 | -3,225 |
| Free Cash Flow | -3,834 | -2,917 | -1,570 | -838 | -3,225 |